DK0492369T3 - Hidtil ukendte tricycliske amino- og nitro-forbindelser med ACE-hæmmende virkning - Google Patents

Hidtil ukendte tricycliske amino- og nitro-forbindelser med ACE-hæmmende virkning

Info

Publication number
DK0492369T3
DK0492369T3 DK91121638.0T DK91121638T DK0492369T3 DK 0492369 T3 DK0492369 T3 DK 0492369T3 DK 91121638 T DK91121638 T DK 91121638T DK 0492369 T3 DK0492369 T3 DK 0492369T3
Authority
DK
Denmark
Prior art keywords
inhibitory effect
hydrogen
amino
nitro compounds
ace inhibitory
Prior art date
Application number
DK91121638.0T
Other languages
English (en)
Inventor
Gary A Flynn
Douglas W Beight
Original Assignee
Merrell Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Pharma Inc filed Critical Merrell Pharma Inc
Application granted granted Critical
Publication of DK0492369T3 publication Critical patent/DK0492369T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/022Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2
    • C07K5/0222Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2 with the first amino acid being heterocyclic, e.g. Pro, Trp
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biochemistry (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK91121638.0T 1990-12-21 1991-12-17 Hidtil ukendte tricycliske amino- og nitro-forbindelser med ACE-hæmmende virkning DK0492369T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US63357290A 1990-12-21 1990-12-21
US77762591A 1991-10-23 1991-10-23

Publications (1)

Publication Number Publication Date
DK0492369T3 true DK0492369T3 (da) 1997-10-13

Family

ID=27091923

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91121638.0T DK0492369T3 (da) 1990-12-21 1991-12-17 Hidtil ukendte tricycliske amino- og nitro-forbindelser med ACE-hæmmende virkning

Country Status (18)

Country Link
EP (1) EP0492369B1 (da)
JP (1) JP3112327B2 (da)
KR (2) KR100220880B1 (da)
CN (1) CN1040985C (da)
AT (1) ATE158303T1 (da)
AU (1) AU642321B2 (da)
CA (1) CA2057786C (da)
DE (1) DE69127681T2 (da)
DK (1) DK0492369T3 (da)
ES (1) ES2108027T3 (da)
FI (1) FI95800C (da)
GR (1) GR3025622T3 (da)
HU (1) HU210167B (da)
IE (1) IE914507A1 (da)
IL (1) IL100416A (da)
NO (1) NO180196C (da)
NZ (1) NZ241023A (da)
PT (1) PT99849B (da)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5308841A (en) * 1990-12-21 1994-05-03 Merrell Dow Pharmaceuticals Inc. Amino and nitro containing tricyclic compounds useful as inhibitors of ACE
US5455242A (en) * 1991-09-27 1995-10-03 Merrell Dow Pharmaceuticals Inc. Carboxyalkyl tricyclic derivatives useful as inhibitors of enkephalinase and ace
US5457196A (en) * 1991-09-27 1995-10-10 Merrell Dow Pharmaceuticals Inc. 2-substituted indane-2-carboxyalkyl derivatives useful as inhibitors of enkephalinase and ACE
EP0534363B1 (en) * 1991-09-27 1997-07-09 Merrell Pharmaceuticals Inc. Novel 2-substituted indane-2-mercaptoacetylamide derivatives useful as inhibitors of enkephalinase and ace
AU657793B2 (en) * 1991-09-27 1995-03-23 Merrell Pharmaceuticals Inc. Novel 2-substituted indane-2-carboxyalkyl derivatives useful as inhibitors of enkephalinase and ACE
CA2078759C (en) * 1991-09-27 2003-09-16 Alan M. Warshawsky Novel carboxyalkyl derivatives useful as inhibitors of enkephalinase and ace
WO1993023403A1 (en) * 1992-05-15 1993-11-25 Merrell Dow Pharmaceuticals Inc. NOVEL MERCAPTOACETYLAMIDO PYRIDAZO[1,2]PYRIDAZINE, PYRAZOLO[1,2]PYRIDAZINE, PYRIDAZO[1,2-a][1,2]DIAZEPINE AND PYRAZOLO[1,2-a][1,2]DIAZEPINE DERIVATIVES USEFUL AS INHIBITORS OF ENKEPHALINASE AND ACE
AU673857B2 (en) * 1992-10-30 1996-11-28 Aventisub Ii Inc. Mercaptoacetylamide bicyclic lactam derivatives
US5362727A (en) * 1993-07-26 1994-11-08 Bristol-Myers Squibb Substituted azepino[2,1-a]isoquinoline compounds
US5525723A (en) * 1993-11-18 1996-06-11 Bristol-Myers Squibb Co. Compounds containing a fused multiple ring lactam
JPH09508906A (ja) * 1994-02-14 1997-09-09 メレル ファーマスーティカルズ インコーポレーテッド エンケファリナーゼ及びaceの阻害剤として有用な新規なメルカプトアセチルアミド1,3,4,5−テトラヒドロベンゾ[c]アゼピン−3−オンジスルフィド誘導体類
CA2183320C (en) * 1994-02-14 1999-10-26 Gary A. Flynn Novel mercaptoacetylamide disulfide derivatives useful as inhibitors of enkephalinase and ace
EP0746566A1 (en) * 1994-02-14 1996-12-11 Merrell Pharmaceuticals Inc. Novel 2-substituted indane-2-mercaptoacetylamide disulfide derivatives useful as inhibitors of enkephalinase and ace
US5530013A (en) * 1994-02-14 1996-06-25 American Home Products Corporation Venlafaxine in the inducement of cognition enhancement
HUT74584A (en) * 1994-02-14 1997-01-28 Merrell Pharma Inc Novel heterocycle fused benzazepine-2-mercaptoacetylamide disulfide derivatives useful as inhibitors of enkephalinase, process for producing them and pharmaceutical compositions containing them
US5484783A (en) * 1994-03-24 1996-01-16 Merrell Dow Pharmaceuticals Inc. Hypocholesterolemic, antiatherosclerotic and hypotriglyceridemic mercaptoacetylamide and benzazapine derivatives
WO1995025532A1 (en) * 1994-03-24 1995-09-28 Merrell Pharmaceuticals Inc. Hypocholesterolemic, antiatherosclerotic and hypotriglyceridemic aminoacetylmercapto derivatives
AU688012B2 (en) * 1994-03-24 1998-03-05 Merrell Pharmaceuticals Inc. Hypocholesterolemic, antiatherosclerotic and hypotriglyceridemic mercaptoacetylamide disulfide derivatives
ATE266040T1 (de) * 1994-12-21 2004-05-15 Aventis Pharma Inc Verfahren zur herstellung von zwischenprodukten von inhibitoren von enkephalinase und angiotensin konvertierendem enzym und zwischenprodukte davon
US5641880A (en) * 1994-12-21 1997-06-24 Hoechst Marion Roussel, Inc. Processes for preparing intermediates of inhibitors of enkephalinase and angiotensin converting enzyme and intermediates thereof
US7078225B2 (en) 2000-06-02 2006-07-18 Nippon Shokubai Co., Ltd. Method for enzymatically producing an optically active cyanohydrin
GB0119305D0 (en) 2001-04-12 2001-10-03 Aventis Pharma Gmbh Mercaptoacetylamide derivatives,a process for their preparation and their use

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4584294A (en) * 1984-11-07 1986-04-22 Merck & Co., Inc. Fused tricyclic lactams as angiotensin converting enzyme inhibitors and as antihypertensive agents
CA1337654C (en) * 1986-06-13 1995-11-28 Gary A. Flynn Fused tricyclic lactams as antihypertensive agents
AU636101B2 (en) * 1987-04-10 1993-04-22 Monash University 1,2,3,4,10,14b-hexahydrodibenzo(c,f)pyrazino-(1,2-a)azepino derivatives and 10-aza, 10-oxa and 10-thia analogues
US4824832A (en) * 1987-12-30 1989-04-25 Merrell Dow Pharmaceuticals Inc. Sulfhydryl containing tricyclic lactams and their pharmacological methods of use
CA2053340C (en) * 1990-10-18 2002-04-02 Timothy P. Burkholder Mercaptoacetylamide derivatives useful as inhibitors of enkephalinase and ace

Also Published As

Publication number Publication date
CA2057786C (en) 2002-06-18
EP0492369A1 (en) 1992-07-01
FI95800C (fi) 1996-03-25
NO180196C (no) 1997-03-05
NO180196B (no) 1996-11-25
FI916017L (fi) 1992-06-22
JPH04342588A (ja) 1992-11-30
DE69127681T2 (de) 1998-01-15
IE914507A1 (en) 1992-07-01
JP3112327B2 (ja) 2000-11-27
PT99849A (pt) 1992-11-30
IL100416A0 (en) 1992-09-06
NO915068D0 (no) 1991-12-20
CN1062729A (zh) 1992-07-15
KR100220880B1 (ko) 1999-09-15
DE69127681D1 (de) 1997-10-23
NO915068L (no) 1992-06-22
PT99849B (pt) 1999-06-30
GR3025622T3 (en) 1998-03-31
IL100416A (en) 1995-11-27
FI916017A0 (fi) 1991-12-19
HU914092D0 (en) 1992-03-30
CN1040985C (zh) 1998-12-02
AU8981991A (en) 1992-06-25
FI95800B (fi) 1995-12-15
KR100220879B1 (ko) 2000-03-15
AU642321B2 (en) 1993-10-14
EP0492369B1 (en) 1997-09-17
HUT60271A (en) 1992-08-28
ATE158303T1 (de) 1997-10-15
ES2108027T3 (es) 1997-12-16
NZ241023A (en) 1994-10-26
KR920012082A (ko) 1992-07-25
HU210167B (en) 1995-02-28
CA2057786A1 (en) 1992-06-22

Similar Documents

Publication Publication Date Title
DK0492369T3 (da) Hidtil ukendte tricycliske amino- og nitro-forbindelser med ACE-hæmmende virkning
EA199900591A1 (ru) АЗОТСОДЕРЖАЩИЕ ГЕТЕРОАРОМАТИЧЕСКИЕ СОЕДИНЕНИЯ В КАЧЕСТВЕ ИНГИБИТОРОВ ФАКТОРА Ха
DK1265606T3 (da) Celleadhæsionsinhibitorer
EA200200446A1 (ru) НОВЫЕ α-АМИНОКИСЛОТНЫЕ СОЕДИНЕНИЯ, СПОСОБ ИХ ПОЛУЧЕНИЯ И ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ, ИХ СОДЕРЖАЩИЕ
HUP0100064A2 (hu) Amidszármazékot és klórtalonilt tartalmazó, szinergetikus fungicid kombináció és alkalmazása
DE69835430D1 (de) Sulfonamidderivate, ihre herstellung und verwendung
CA2079143A1 (en) Novel 2-substituted indane-2-carboxyalkyl derivatives useful as inhibitors of enkephalinase and ace
BRPI0014526C1 (pt) compostos cíclicos de seis elementos contendo nitrogênio aromático, composição farmacêutica e uso do mesmo
DK0624584T3 (da) Piperazinderivater, der er nyttige som calmodulininhibitorer
DK0759899T3 (da) Nitroforbindelser og sammensætninger deraf med antiinflammatoriske, analgetiske og antitrombotiske aktiviteter
AU2910600A (en) Phenyl urea and phenyl thiourea derivatives
DK0790987T3 (da) Aminotetrazol-derivater, der er anvendelige som nitrogenoxidsynthaseinhibitorer
CO4920250A1 (es) Compuestos heterociclicos utiles en la inhibicion de la spla2
NO20052976L (no) Fosfodiesterase-4-inhibitorer.
DE60107435D1 (de) 2-adamantylethylamine und deren verwendung bei der behandlung von abnormalitäten in der glutamat transmission
DE3853577D1 (de) Benzyliden-Malononitril-Derivate zur Hemmung von proliferativen Prozessen in Säugetierzellen.
BG105417A (en) Derivatives of isosorbid mononitrate, utilization as vasodilator agents with reduced tolerance
BR0004535A (pt) Compostos, e, uso dos mesmos.
WO2001010834A3 (en) Antibacterial agents
DE69924887D1 (de) Antibakterielle mittel
UA26459C2 (uk) Іhгібітор впливу амілоїдhих білків
GB8823405D0 (en) Aryloxy-arythio-heteraryloxy-heteroarylthio-alkenylene derivatives of amines
NO20003075D0 (no) Nervebeskyttende midler
ATE65986T1 (de) Propanolabkoemmlinge.
NO954764D0 (no) Psoralen-derivater, deres fremstilling og anvendelse